Proceedings of the National Academy of Sciences · 1990 · 153 citations · 13 references
Veterinary MedicineImmunologyPhysiologyImmunopathologyImmunophysiologyInflammationAcute InflammationAnti-inflammatory PharmacologyIschemic Heart DiseaseMetabolic InflammationOxidative Stress In InflammationOxidative Stress PhysiologyGlucose-6-phosphate Dehydrogenase RegulationInflammatory Cytokine EffectsIschemia-reperfusion Oxidative InjuryMyocardial Ischemia-reperfusion InjuryOxidative Stress In Cardiovascular DiseaseOxidative Stress In Ischemia-reperfusion InjuryOxidative Stress InjuryPretreatment
Hearts isolated from rats treated 36 hr before with interleukin 1 (IL-1) had increased glucose-6-phosphate dehydrogenase (G6PD) activity and decreased hydrogen peroxide levels and injury after global ischemia (I, 20 min)/reperfusion (R, 40 min) compared with hearts from untreated rats. Hearts isolated from rats treated 6 hr earlier with IL-1 also had increased polymorphonuclear leukocytes (PMN), H2O2 levels, and oxidized glutathione (GSSG) contents compared with hearts from untreated rats. Depletion of circulating blood PMN by prior treatment with vinblastine prevented both early (from treatment 6 hr before study) IL-1-induced increases in myocardial PMN accumulation, H2O2 levels, and GSSG contents and late (from treatment 36 hr before study) increases in myocardial G6PD activity and protection against I/R. Our results indicate that IL-1 pretreatment causes an early (6 hr after IL-1 treatment) myocardial PMN accumulation and most likely an H2O2-dependent oxidative stress, which contributes to late (36 hr after IL-1 treatment) increases in myocardial G6PD activity and decreases in I/R injury.
13
Janet M. Brown, Michael Grosso, Lance S. Terada et al. · Proceedings of the National Academy of Sciences · 1989 · 266 citations · Full text
Medicine, Cardiology, Pharmacology +13